Does GOSERELIN Cause Myelosuppression? 100 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 100 reports of Myelosuppression have been filed in association with GOSERELIN (ZOLADEX). This represents 1.6% of all adverse event reports for GOSERELIN.
100
Reports of Myelosuppression with GOSERELIN
1.6%
of all GOSERELIN reports
4
Deaths
43
Hospitalizations
How Dangerous Is Myelosuppression From GOSERELIN?
Of the 100 reports, 4 (4.0%) resulted in death, 43 (43.0%) required hospitalization, and 8 (8.0%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GOSERELIN. However, 100 reports have been filed with the FAERS database.
What Other Side Effects Does GOSERELIN Cause?
Death (1,293)
Malignant neoplasm progression (935)
Metastases to bone (397)
Neutropenia (339)
Fatigue (309)
Off label use (272)
Metastases to liver (264)
Hot flush (263)
Asthenia (213)
Arthralgia (190)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
Which GOSERELIN Alternatives Have Lower Myelosuppression Risk?
GOSERELIN vs GRAMICIDIN
GOSERELIN vs GRAMICIDIN\NEOMYCIN\POLYMYXIN B
GOSERELIN vs GRAMICIDIN\POLYMYXIN B
GOSERELIN vs GRANISETRON
GOSERELIN vs GRANULOCYTE COLONY-STIMULATING FACTOR NOS